MyProstateScore in men considering repeat biopsy: validation of a simple testing approach.

Jeffrey J TosoianMichael S SessineBruce J TrockAshley Evan RossCassie XieYingye ZhengNathan L SamoraJaved SiddiquiYashar NiknafsZoey ChopraScott TomlinsLakshmi P KunjuGanesh S PalapattuTodd M MorganJohn T WeiSimpa S SalamiArul M Chinnaiyan

Published in: Prostate cancer and prostatic diseases (2022)

In patients who previously underwent a negative prostate biopsy, the MyProstateScore values of 15 and 40 yielded clinically-actionable rule-in and rule-out risk groups. Using this straightforward testing approach, MyProstateScore can meaningfully inform patients and physicians weighing the need for repeat biopsy.

Keyphrases

ultrasound guided
end stage renal disease
fine needle aspiration
prostate cancer
ejection fraction
newly diagnosed
primary care
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes
benign prostatic hyperplasia
patient reported